Immatics (IMTX) Chief Development Officer files Form 3 detailing equity

Rhea-AI Filing Summary

Immatics N.V. Chief Development Officer Carsten Alexander Johannes Reinhardt filed a Form 3 reporting his initial ownership in the company. He holds 47,781 Ordinary Shares directly, a series of stock options to buy additional Ordinary Shares at exercise prices ranging from $1.06 to $11.00 with expirations between 2027 and 2036, and 40,000 restricted stock units that vest in four equal annual installments beginning on January 8, 2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reinhardt Carsten Alexander Johannes

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Development Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	47,781	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	07/01/2027	Ordinary Shares	18,753	$1.06	D
Stock Option (Right to Buy)	(1)	06/30/2030	Ordinary Shares	214,748	$10	D
Stock Option (Right to Buy)	(2)	06/30/2030	Ordinary Shares	255,000	$10	D
Stock Option (Right to Buy)	(1)	12/17/2030	Ordinary Shares	49,000	$9.68	D
Stock Option (Right to Buy)	(1)	12/08/2031	Ordinary Shares	98,000	$11	D
Stock Option (Right to Buy)	(3)	12/12/2032	Ordinary Shares	90,000	$9.75	D
Stock Option (Right to Buy)	(4)	12/04/2033	Ordinary Shares	92,000	$9.06	D
Stock Option (Right to Buy)	(5)	12/02/2034	Ordinary Shares	88,000	$8.06	D
Stock Option (Right to Buy)	(6)	01/07/2036	Ordinary Shares	160,000	$9.32	D
Restricted Stock Units	(7)	(7)	Ordinary Shares	40,000	$0	D

Explanation of Responses:

1. These options to purchase ordinary shares of the Issuer ("Ordinary Shares," and each such option, an "Option") are fully vested.

2. These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, June 30, 2020, and 6.25% of the Options on each quarterly anniversary of such date over the following three years.

3. These Options vest 25% on the first anniversary of the grant date, December 13, 2022, then in 12 equal quarterly installments over the following three years.

4. These Options vest 25% on the first anniversary of the grant date, December 5, 2023, then in 12 equal quarterly installments over the following three years.

5. These Options vest 25% on the first anniversary of the grant date, December 3, 2024, then in 12 equal quarterly installments over the following three years.

6. These Options vest 25% on the first anniversary of the grant date, January 8, 2026, then in 12 equal quarterly installments over the following three years.

7. Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share. These RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Edward Sturchio, attorney-in-fact for Carsten Alexander Johannes Reinhardt	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Immatics (IMTX) Form 3 filing by the Chief Development Officer report?

The Form 3 reports Chief Development Officer Carsten Alexander Johannes Reinhardt’s initial ownership in Immatics N.V. It lists his directly held Ordinary Shares, multiple stock option awards with specified exercise prices and expirations, and restricted stock units that vest over time starting in January 2026.

How many Immatics (IMTX) Ordinary Shares does the CDO directly own in this Form 3?

The filing shows direct ownership of 47,781 Immatics Ordinary Shares. This figure represents his current equity stake in actual shares, separate from his stock options and restricted stock units, which give rights to acquire additional Ordinary Shares in the future upon vesting or exercise.

What stock options are reported for the Immatics (IMTX) Chief Development Officer?

The Form 3 lists several stock option grants to buy Ordinary Shares, including options with a $1.06 exercise price expiring on July 1, 2027 and others with prices such as $10.00, $9.68, $9.75, $9.06, $8.06, and $9.32 expiring between 2030 and 2036.

How are the Immatics (IMTX) stock options for the CDO structured to vest over time?

Footnotes explain several option grants vest 25% on the first anniversary of their grant dates, then in 12 equal quarterly installments over the following three years. This schedule applies to grants dated December 13, 2022, December 5, 2023, December 3, 2024, and January 8, 2026.

What restricted stock units (RSUs) does the Immatics (IMTX) Chief Development Officer hold?

The Form 3 reports 40,000 restricted stock units, each representing a contingent right to receive one Ordinary Share. According to the footnotes, these RSUs vest in four equal annual installments on each anniversary of the grant date, starting on January 8, 2026.

Do the Immatics (IMTX) options in this Form 3 have performance conditions?

One group of options is described as eligible to be earned based on specified market capitalization performance hurdles and service-vesting conditions. Service-vesting was 25% on June 30, 2020, then 6.25% on each quarterly anniversary over the following three years, aligning vesting with tenure and performance.